124 related articles for article (PubMed ID: 9610742)
1. Alendronate/interleukin-1beta cotreatment increases interleukin-6 in bone and UMR-106 cells: dose dependence and relationship to the antiresorptive effect of alendronate.
Sanders JL; Tarjan G; Foster SA; Stern PH
J Bone Miner Res; 1998 May; 13(5):786-92. PubMed ID: 9610742
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures.
Tarjan G; Stern PH
J Bone Miner Res; 1995 Sep; 10(9):1321-6. PubMed ID: 7502703
[TBL] [Abstract][Full Text] [Related]
3. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption.
Radeff JM; Nagy Z; Stern PH
Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844
[TBL] [Abstract][Full Text] [Related]
4. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T
J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830
[TBL] [Abstract][Full Text] [Related]
5. Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture.
Engel E; Serrano S; Mariñoso ML; Lloreta J; Ulloa F; Nogués X; Diez-Pérez A; Carbonell J
Calcif Tissue Int; 2003 Mar; 72(3):228-35. PubMed ID: 12522661
[TBL] [Abstract][Full Text] [Related]
6. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
7. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
Chabaud M; Miossec P
Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
[TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-6 expression in human osteoblastic cells in vitro.
Hierl T; Börcsök I; Sommer U; Ziegler R; Kasperk C
Exp Clin Endocrinol Diabetes; 1998; 106(4):324-33. PubMed ID: 9792466
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression.
Dovio A; Sartori ML; Masera RG; Racca S; Angeli A
Cytokine; 2001 Jul; 15(1):47-52. PubMed ID: 11509008
[TBL] [Abstract][Full Text] [Related]
10. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17: A new bone acting cytokine in vitro.
Van bezooijen RL; Farih-Sips HC; Papapoulos SE; Löwik CW
J Bone Miner Res; 1999 Sep; 14(9):1513-21. PubMed ID: 10469279
[TBL] [Abstract][Full Text] [Related]
12. Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression.
Jin UH; Kim DI; Lee TK; Lee DN; Kim JK; Lee IS; Kim CH
J Ethnopharmacol; 2006 Jul; 106(3):333-43. PubMed ID: 16513308
[TBL] [Abstract][Full Text] [Related]
13. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
14. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
Kumar S; Votta BJ; Rieman DJ; Badger AM; Gowen M; Lee JC
J Cell Physiol; 2001 Jun; 187(3):294-303. PubMed ID: 11319753
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.
Linkhart TA; Linkhart SG; MacCharles DC; Long DL; Strong DD
J Bone Miner Res; 1991 Dec; 6(12):1285-94. PubMed ID: 1792940
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of antigen-presenting cell function by alendronate in vitro.
Sansoni P; Passeri G; Fagnoni F; Mohagheghpour N; Snelli G; Brianti V; Engleman EG
J Bone Miner Res; 1995 Nov; 10(11):1719-25. PubMed ID: 8592949
[TBL] [Abstract][Full Text] [Related]
17. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
18. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC; Ten RM; Khosla S
J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
[TBL] [Abstract][Full Text] [Related]
19. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6.
Sylvester FA; Wyzga N; Hyams JS; Gronowicz GA
J Bone Miner Res; 2002 Apr; 17(4):695-702. PubMed ID: 11918227
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
